Special clinical interest in colorectal, head and neck.
Dr Freebairn helped set up the skin cancer multi-disciplinary team in the Royal Berkshire Hospital, Reading with plastic surgeons and dermatologists in 2003, and is an integral member of the Oxford/Reading Head and Neck Cancer Multi-Disciplinary Team and the Reading Colorectal Multi-Disciplinary Team.
Dr Dallas and Dr Freebairn have introduced Head & Neck Intensity Modulated Radiotherapy (IMRT) to all Reading patients.
Dr Gildersleve and Dr Freebairn have also introduced IMRT for patients with anal cancer. Dr Freebairn is in the process of leading a project at the Royal Berkshire Hospital to bring in an acute oncology service at the weekends.
Intensity modulated radiotherapy (IMRT), Chemotherapy
Colorectal, head & neck and skin cancers
NHS Hospital / current post(s)
Consultant Clinical Oncologist
Royal Berkshire Hospital
Head and neck cancer
Involvement in national bowel cancer clinical trials including the SCOT trial. This looks at the length of chemotherapy needed in bowel cancer.
The COIN trial looked at the best duration of palliative chemotherapy for patients with bowel cancer.
Dr Freebairn is also working with Dr Nicola Dallas in setting up the Pathos trial which is looking at the best dose and techniques for the radiotherapy of oropharyngeal cancer.
Dr Freebairn and Dr Dallas are also setting up the PLATO trial, looking at radiotherapy and dosages for the treatment of anal cancer.
Fellow of the Royal College of Radiologists (FRCR), Fellow of the Royal College of Physicians (FRCP), member of the Royal College of Physicians (MRCP) ,